Summary>Summary In December, CDE undertook 1,366 drug registration applications>
The TOP20 market for tens of billions of cold Chinese patent medicines is released! 2 billion large
Time of Update: 2021-12-06
varieties, namely Lianhua Qingwen Capsules and Lianhua Qingwen Granules of Yiling Pharmaceutical, Antiviral Granules of Sichuan Everbright Pharmaceutical, Four Seasons Antiviral Mixture of Shaanxi Haitian Pharmaceutical, Yunnan Baiyao Group Shangfengting
The TOP20 market for tens of billions of cold Chinese patent medicines is released! 2 billion large varieties lead 6 exclusive lists
Time of Update: 2021-12-06
products are exclusive varieties, namely Lianhua Qingwen Capsules and Lianhua Qingwen Granules of Yiling Pharmaceutical, Antiviral Granules of Sichuan Everbright Pharmaceutical, Four Seasons Antiviral Mixture of Shaanxi Haitian Pharmaceutical, Yunnan Baiyao
Announcement on the inclusion of 6 substances including methyl 3-oxo-2-phenylbutyrate in the management of precursor chemicals
Time of Update: 2021-11-16
-phenylbutyrate, 3-oxo-2-phenylbutanamide, 2-methyl-3-[3,4-(methylenedioxy)phenyl]glycidol Management of acid and methyl 2-methyl-3-[3,4-(methylenedioxy)phenyl]glycidate>1. Methyl 3-oxo-2-phenylbutyrate
Lancet Rheumatology: Inhibition of IL-1 and IL-6 affects the neutralizing activity of anti-SARS-CoV-2 antibodies in COVID-19 patients
Time of Update: 2021-11-12
Conclusion: IL-1 and IL-6 inhibitors used in the treatment of severe COVID-19 patients will affect the neutralizing activity of anti- SARS-CoV-2 antibodies .
Scientists have discovered a highly effective antibody with 4-6 months of protection against SARS-CoV-2
Time of Update: 2021-10-21
The newly identified antibody was isolated from the lymphocytes of COVID-19 patients who participated in the immunization coronavirus research conducted by CHUV's Immunization and Allergy Service Center .
Announcement on the inclusion of 6 substances including methyl 3-oxo-2-phenylbutyrate and 3-oxo-2-phenylbutanamide in the management of precursor chemicals
Time of Update: 2021-09-12
Regarding the combination of methyl 3-oxo-2-phenylbutyrate, 3-oxo-2-phenylbutanamide, 2-methyl-3-[3,4-(methylenedioxy)phenyl]glycidol Acid, 2-methyl-3-[3,4-(methylenedioxy)phenyl
Product performance and application of 2-amino-8-naphthol-6-sulfonic acid
Time of Update: 2021-08-28
The acidified product is ammoniated with ammonia to obtain 2-amino-8-naphthol-6-ammonium sulfonate, and finally the product is obtained by acid precipitation .
Production process and product use of 6-methoxy-2-naphthaleneethanone
Time of Update: 2021-08-11
is generally 92% . Acetylation is completed by reacting with acetyl chloride using nitrobenzene as a solvent . >(2) The 1
Raising over 2 billion in 6 years and holding 940 million in revenue, medical technology company Zero Krypton wants to be listed on NASDAQ
Time of Update: 2021-06-28
data collection to data applications, B-side empowerment to C-side services . > Among them, LinkData, as an AI data governance system independently developed by Zerokrypton
Tianjing Bio-IL-6 trans-signaling pathway inhibitor olamkicept has been successful in the treatment of ulcerative colitis (UC) phase 2 clinical trial!
Time of Update: 2021-06-19
The study has reached the primary endpoint and key secondary endpoints: (1) After 12 weeks of treatment, with placebo Compared with the drug group, the 600mg dose olamkicept group showed a significantly higher clinical response rate (p=0.
The Central Environmental Protection Inspection Team completed the stationing of 2 central
Time of Update: 2021-06-19
Global Coatings Network News:> On the afternoon of July 15, the Central Second Ecological and Environmental Protection Inspectorate's mobilization meeting
of advanced gastric cancer (6) ——Progress in systemic drug therapy for recurrence or metastasis of advanced gastric cancer (2)
Time of Update: 2021-06-11
/> The median OS of CR or partial response (PR) patients was 26. 6 months, the 1-year OS rate was 87. 1%, the 2-year OS rate was 61. 3%, and no new TRAEs were found during follow-up .
Hengrui Medicine's application for the listing of CDK 4/6 inhibitors has been accepted and R&D investment nearly 2...
Time of Update: 2021-05-10
On April 27, the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China announced that Hengrui Medicine's Class 1 new drug CDK 4/6 inhibitor SHR6390 tablets had submitted a new drug marketing application and was accepted.
Notice of hefei Municipal Market Supervision Administration on the non-conformity of 2 batches of food products (No. 6 Of 2021)
Time of Update: 2021-02-24
Recently, Hefei Municipal Market Supervision and Administration organized sampling of edible agricultural products, food and beverage products, food processing products, dairy products, cooking oil, grease and its products, condiments and other 6
Notice of the Nanjing Municipal Market Supervision Bureau on the Non-conformity of 6 Batches of Food (No. 2 of 2021)
Time of Update: 2021-01-25
2, Nanjing Yuhuatai District Cui Yuheng restaurant used in the use of reusable catering equipment (chopsticks), anion synthetic detergent (with sodium xyranyl benzoate meter) does not meet the requirements of food safety standards.
Professors Zhang Yan and Wang Shuo, Nanjia University: 2-amino-1-methyl-6-benzene-based methane and the composition of intestinal bacteria in rats
Time of Update: 2021-01-12
biological antibody 3. Quality and safety control technology of food processing 4. Food safety risk assessment yl-6-phenylimidazo .4,5-b'pyridine Colon Injury by Disrupting the Intestinal Berry Composition and Lipid Metabolic Pathways in Rats published online at Journal of Agricultural and Food Chemistry.
